Kuniharu Mizuno

Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats

Noriaki Kato, Kuniharu Mizuno, Mitsuhiro Makino et al. · Diabetes Research and Clinical Practice · 2000 · 59 citations

Metabolic Syndrome, Experimental Diabetic Neuropathy, Medicine +9

Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2′,5′-dioxospiro[chroman-4,4′-imidazolidine]-2-carboxamide (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats

Kuniharu Mizuno, Noriaki Kato, Akira Matsubara et al. · Metabolism · 1992 · 43 citations

Peripheral Nerve, Peripheral Nerves, Experimental Pharmacology +16

Continuous Inhibition of Excessive Polyol Pathway Flux in Peripheral Nerves by Aldose Reductase Inhibitor Fidarestat Leads to Improvement of Diabetic Neuropathy

Kuniharu Mizuno, Noriaki Kato, Mitsuhiro Makino et al. · Journal of Diabetes and its Complications · 1999 · 36 citations

Medicine, Physiology, Diabetes +7

Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.

K Kojima, Hisashi Matsubara, Tokiko Harada et al. · PubMed · 1985 · 28 citations

Determination of monosaccharides and sugar alcoholsin tissues from diabetic rats by high-performance liquid chromatography with pulsed amperometric detection

Noboru Tomiya, Takeshi Suzuki, Juichi Awaya et al. · Analytical Biochemistry · 1992 · 24 citations

Medicine, Bioanalysis, Diabetes +10